The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells

被引:0
|
作者
Gohar Karapetyan
Katarine Fereshetyan
Hayk Harutyunyan
Konstantin Yenkoyan
机构
[1] Yerevan State Medical University named after M. Heratsi,Neuroscience Laboratory, Cobrain Center
[2] Yerevan State Medical University named after M. Heratsi,Department of Biochemistry
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe2+) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro.
引用
收藏
相关论文
共 50 条
  • [41] Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)
    Varadarajan, S
    Kanski, J
    Aksenova, M
    Lauderback, C
    Butterfield, DA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (24) : 5625 - 5631
  • [42] Oxidative stress induced by intracerebroventricular amyloid beta protein (1-42) injection
    Lee, DY
    Jhoo, JH
    Kim, HC
    Woo, SI
    Youn, JC
    Woo, JI
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1071 - 1072
  • [43] Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice
    Prokop, Stefan
    Miller, Kelly R.
    Drost, Natalia
    Handrick, Susann
    Mathur, Vidhu
    Luo, Jian
    Wegner, Anja
    Wyss-Coray, Tony
    Heppner, Frank L.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (11): : 1811 - 1818
  • [44] Gastrodin Protects Neural Progenitor Cells Against Amyloid β (1-42)-Induced Neurotoxicity and Improves Hippocampal Neurogenesis in Amyloid β (1-42)-Injected Mice
    Li, Meng
    Qian, Sumin
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 60 (01) : 21 - 32
  • [45] Metals, Amyloid and Oxidative Stress in Alzheimer's Disease
    Bush, A. I.
    Mok, S. S.
    PROCEEDINGS OF THE XIV BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, 2008, : 1 - 4
  • [46] Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease
    Zhiyou Cai
    Bin Zhao
    Anna Ratka
    NeuroMolecular Medicine, 2011, 13 : 223 - 250
  • [47] Oxidative Stress and β-Amyloid Protein in Alzheimer's Disease
    Cai, Zhiyou
    Zhao, Bin
    Ratka, Anna
    NEUROMOLECULAR MEDICINE, 2011, 13 (04) : 223 - 250
  • [48] Decreased serum amyloid β1-42 autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide
    Brettschneider, S
    Morgenthaler, NG
    Teipel, SJ
    Fischer-Schulz, C
    Bürger, K
    Dodel, R
    Du, YS
    Möller, HJ
    Bergmann, A
    Hampel, H
    BIOLOGICAL PSYCHIATRY, 2005, 57 (07) : 813 - 816
  • [49] Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease (vol 142, pg 1, 2019)
    Park, Jong-Chan
    Han, Sun-Ho
    Yi, Dahyun
    Byun, Min Soo
    Lee, Jun Ho
    Jang, Sukjin
    Ko, Kang
    Jeon, So Yeon
    Lee, Yun-Sang
    Kim, Yu Kyeong
    Lee, Dong Young
    Mook-Jung, Inhee
    BRAIN, 2019, 142
  • [50] A novel method to study aggregation of amyloid β1-42 -: a key peptide associated with Alzheimer's Disease
    Sun, Zhengfei
    Patel, Alpa C.
    Yuan, Jian Min
    Schweitzer-Stenner, Reinhard
    Wei, Yen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231